Table 2.
The prevalence of uterine fibroids in female study participants grouped according to different levels of serum 25-hydroxyvitamin D (25OHD).
| Serum 25OHD level, ng/ml |
Participant group |
Total | χ2 values | Statistical significance | |
|---|---|---|---|---|---|
| With fibroids | Without fibroids | ||||
| <12 | 40 (65.57) | 21 (34.43) | 61 | 14.57 | P < 0.05 |
| 12–20 | 141 (55.73) | 112 (44.27) | 253 | ||
| >20 | 98 (42.24)*△ | 134 (57.76) | 232 | ||
| Total, n | 279 | 267 | 546 | ||
Data presented as n (%) prevalence.
P < 0.05 was considered statistically significant. *P < 0.05 versus prevalence of fibroids in women with deficient 25OHD levels (<12 ng/ml); △P < 0.05 versus prevalence of fibroids in women with insufficient 25OHD levels (12–20 ng/ml).